glp-1 lawsuits news today ad war leads to lawsuit by Novo Nordisk, claiming Eli Lilly misleads GLP-1 Injury Lawsuit: Legal Help

While nausea, vomiting, and diarrhea are the most commonly reported gastrointestinal adverse effects with GLP-1-based therapies (occurring in 15-40% of patients depending on the agent and dose), FDA prescribing information for several of these medications does list dyspepsia (indigestion) and, in some cases, gastroesophageal reflux disease (GERD) as reported adverse reactions

Liver Regeneration Is Transiently Impaired in Urokinase-Deficient Mice

Identified that the CgMYB1 transcription factors, a member of the R2R3-MYB TF family

Nadolsky notes, a higher 7.2 mg dose may be released in the future

Haghighatdoost F, Jabbari M, Hariri M (2019) The effect of L-carnitine on inflammatory mediators: a systematic review and meta-analysis of randomized clinical trials

All other data can be found within the main text, Supplementary information or Source Data files